Brandon Capital Partners
Venture capitalSeed–Growth
Investment thesis
Brandon Capital is a life sciences venture capital firm that invests in biotech and medical research companies, with investors and venture partners across Australia, New Zealand, the United States and the United Kingdom.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 6 of 7 portfolio companiesBiotech ×6Medical Devices ×4Digital Health ×3Healthtech ×3Deep Tech ×2Impact & Social Good ×1Longevity ×1
HQs:Australia×2United States×2United Kingdom×1
Investments · 7 tracked
founders shown can be your intro path
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundCure Kids VenturesTenmile
Brandon BioCatalyst funds biomedical development opportunities associated with its Member Institutes, offering investments ranging from AU$500,000 to AU$30 million across stages from proof-of-concept to late-stage technologies.
BiotechDeep TechDigital HealthHealthtechImpact & Social GoodMedical Devices
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health.
BiotechDigital HealthHealthtechMedical Devices
Mark Mallon(Chief Executive Officer)inProfessor Anthony Rodgers(Chief Medical Officer)Dr Karl Roberts(Chief Operating Officer)in
Co-investorsBrandon BioCatalyst
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon BioCatalyst
Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.
BiotechMedical DevicesLondon, GB
Co-investorsNovo HoldingsSofinnova PartnersAbingworth
Therapies for fibrotic and inflammatory diseases associated with diabetes complications
Co-investorsStoic VCBrandon BioCatalyst
Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization.
BiotechMedical DevicesSan Francisco, US
Co-investorsBrandon BioCatalyst
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Brandon Capital Partners invest at?
- Brandon Capital Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Brandon Capital Partners focus on?
- Brandon Capital Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Who does Brandon Capital Partners co-invest with?
- Brandon Capital Partners most often shares deals with Brandon BioCatalyst, Novo Holdings, Sofinnova Partners, among 3 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.